USADA announced today that Mairbek Taisumov, of Vienna, Austria, has accepted a six-month sanction for a violation of the UFC® Anti-Doping Policy after testing positive for a prohibited substance.
Taisumov, 30, tested positive for stanozolol metabolites 3′-hydroxystanozolol-O-glucuronide and 16β-hydroxystanozolol-O-glucuronide as the result of an in-competition urine sample he provided on September 15, 2018 at UFC Fight Night in Moscow, Russia. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Following notification of his positive test, Taisumov provided USADA with information about dietary supplement products he was using before and at the time of the relevant sample collection.